Assessing a penalty on unsupported prescription drug price increases to protect the safety, health, and economic well-being of Washington residents. Requires the Health Care Authority to assess a penalty against a drug manufacturer on revenue generated from a price increase on a prescription drug that is not supported by clinical evidence; prohibits manufacturers from withdrawing a drug from the market to avoid paying the penalty.